143 related articles for article (PubMed ID: 37883579)
1. Injectable Zwitterionic Physical Hydrogel with Enhanced Chemodynamic Therapy and Tumor Microenvironment Remodeling Properties for Synergistic Anticancer Therapy.
Fang Y; Huang S; Hu Q; Zhang J; King JA; Wang Y; Wei Z; Lu J; He Z; Kong X; Yang X; Ji J; Li J; Zhai G; Ye L
ACS Nano; 2023 Dec; 17(24):24883-24900. PubMed ID: 37883579
[TBL] [Abstract][Full Text] [Related]
2. Zwitterionic Injectable Hydrogel-Combined Chemo- and Immunotherapy Medicated by Monomolecular Micelles to Effectively Prevent the Recurrence of Tumor Post Operation.
Wang R; Hu Q; Huang S; Fang Y; Kong X; Kaur P; Zhang J; Wang Y; Liu D; Wu H; Li Y; Ji J; Yang X; Ye L; Zhai G
ACS Appl Mater Interfaces; 2024 Jan; 16(3):4071-4088. PubMed ID: 38194589
[TBL] [Abstract][Full Text] [Related]
3. Long-Acting Nanohybrid Hydrogel Induces Persistent Immunogenic Chemotherapy for Suppressing Postoperative Tumor Recurrence and Metastasis.
Li Y; Zhu J; Yang Y; Chen Y; Liu L; Tao J; Chen H; Deng Y
Mol Pharm; 2023 Dec; 20(12):6345-6357. PubMed ID: 37942616
[TBL] [Abstract][Full Text] [Related]
4. In situ gel implant for postsurgical wound management and extended chemoimmunotherapy against breast cancer recurrence.
Wang M; Wang S; Pan Y; Yu R; Zhang ZR; Fu Y
Acta Biomater; 2022 Jan; 138():168-181. PubMed ID: 34755605
[TBL] [Abstract][Full Text] [Related]
5. Implantable 3D Printed Hydrogel Scaffolds Loading Copper-Doxorubicin Complexes for Postoperative Chemo/Chemodynamic Therapy.
Dang W; Wang Y; Chen WC; Ju E; Mintz RL; Teng Y; Zhu L; Wang K; Lv S; Chan HF; Tao Y; Li M
ACS Appl Mater Interfaces; 2023 Feb; 15(4):4911-4923. PubMed ID: 36656977
[TBL] [Abstract][Full Text] [Related]
6. A homologous-targeting cGAS-STING agonist multimodally activates dendritic cells for enhanced cancer immunotherapy.
Wang P; Wang Y; Li H; Wang M; Wang Y; Wang X; Ran L; Xin H; Ma J; Tian G; Gao W; Zhang G
Acta Biomater; 2024 Mar; 177():400-413. PubMed ID: 38336268
[TBL] [Abstract][Full Text] [Related]
7. Co-delivery of doxorubicin and STING agonist cGAMP for enhanced antitumor immunity.
Xie Y; Li K; Liang J; Wang K; Gong Z; Chen X
Int J Pharm; 2024 Apr; 654():123955. PubMed ID: 38423155
[TBL] [Abstract][Full Text] [Related]
8. H
Tang Z; Jiang S; Tang W; He Q; Wei H; Jin C; Wang S; Zhang H
Mol Pharm; 2023 Mar; 20(3):1717-1728. PubMed ID: 36809003
[TBL] [Abstract][Full Text] [Related]
9. A manganese-phenolic network platform amplifying STING activation to potentiate MRI guided cancer chemo-/chemodynamic/immune therapy.
Pang X; Fu C; Chen J; Su M; Wei R; Wang Y; Lin W; Wei X; Jiang X; Yang X; Yang H; Wang J; Yang R
Biomater Sci; 2023 May; 11(11):3840-3850. PubMed ID: 37074080
[TBL] [Abstract][Full Text] [Related]
10. Thermoresponsive injectable self-healing hydrogel containing polydopamine-coated Fe/Mo-doped TiO
Xu S; Qian Z; Zhao N; Yuan W
J Colloid Interface Sci; 2024 Jan; 654(Pt B):1431-1446. PubMed ID: 37922629
[TBL] [Abstract][Full Text] [Related]
11. Drug-loaded implantable surgical cavity-adaptive hydrogels for prevention of local tumor recurrence.
Zhuang B; Chen T; Xiao Z; Jin Y
Int J Pharm; 2020 Mar; 577():119048. PubMed ID: 31978462
[TBL] [Abstract][Full Text] [Related]
12. An injectable PC
Yang J; Wang XJ; Li SM; Jiang DX; Liu YX; Huang Y; Dong DD; Hu W; Liu B
J Biomater Sci Polym Ed; 2024 Feb; 35(2):190-205. PubMed ID: 37851402
[TBL] [Abstract][Full Text] [Related]
13. Aptamer-conjugated nano-liposome for immunogenic chemotherapy with reversal of immunosuppression.
Kim M; Lee JS; Kim W; Lee JH; Jun BH; Kim KS; Kim DE
J Control Release; 2022 Aug; 348():893-910. PubMed ID: 35760233
[TBL] [Abstract][Full Text] [Related]
14. Injectable Magnetic Hydrogel Filler for Synergistic Bone Tumor Hyperthermia Chemotherapy.
Hu P; Lu J; Li C; He Z; Wang X; Pan Y; Zhao L
ACS Appl Bio Mater; 2024 Mar; 7(3):1569-1578. PubMed ID: 38349029
[TBL] [Abstract][Full Text] [Related]
15. TRAIL-modified, doxorubicin-embedded periodic mesoporous organosilica nanoparticles for targeted drug delivery and efficient antitumor immunotherapy.
Feng X; Li F; Zhang L; Liu W; Wang X; Zhu R; Qiao ZA; Yu B; Yu X
Acta Biomater; 2022 Apr; 143():392-405. PubMed ID: 35259519
[TBL] [Abstract][Full Text] [Related]
16. Ferritin-Based Nanocomposite Hydrogel Promotes Tumor Penetration and Enhances Cancer Chemoimmunotherapy.
Liu R; Liang Q; Luo JQ; Li YX; Zhang X; Fan K; Du JZ
Adv Sci (Weinh); 2024 Jan; 11(3):e2305217. PubMed ID: 38029345
[TBL] [Abstract][Full Text] [Related]
17. A prodrug hydrogel with tumor microenvironment and near-infrared light dual-responsive action for synergistic cancer immunotherapy.
Ding M; Fan Y; Lv Y; Liu J; Yu N; Kong D; Sun H; Li J
Acta Biomater; 2022 Sep; 149():334-346. PubMed ID: 35779775
[TBL] [Abstract][Full Text] [Related]
18. Multifunctional STING-Activating Mn
Zhou M; Wang X; Lin S; Cheng Y; Zhao S; Lin J; Fang Z; Lou Z; Qin L; Wei H
Adv Healthc Mater; 2020 Jul; 9(13):e2000064. PubMed ID: 32484320
[TBL] [Abstract][Full Text] [Related]
19. STING Activator c-di-GMP-Loaded Mesoporous Silica Nanoparticles Enhance Immunotherapy Against Breast Cancer.
Chen YP; Xu L; Tang TW; Chen CH; Zheng QH; Liu TP; Mou CY; Wu CH; Wu SH
ACS Appl Mater Interfaces; 2020 Dec; 12(51):56741-56752. PubMed ID: 33305564
[TBL] [Abstract][Full Text] [Related]
20. Fibronectin-Coated Metal-Phenolic Networks for Cooperative Tumor Chemo-/Chemodynamic/Immune Therapy via Enhanced Ferroptosis-Mediated Immunogenic Cell Death.
Xu Y; Guo Y; Zhang C; Zhan M; Jia L; Song S; Jiang C; Shen M; Shi X
ACS Nano; 2022 Jan; 16(1):984-996. PubMed ID: 35023715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
